SCHEMBL13898518

SCHEMBL13898518

C#CCNc1nc(Nc2ccc(NC(=O)OCC(C)C)cc2)ncc1Br

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 16/20 0.60
CDK2 P24941 15/20 0.60
CCNB1 P14635 3/20 0.60
CCNE1 P24864 3/20 0.60
CA2 P00918 4/20 0.59
KDR P35968 13/20 0.44
CDK4 P11802 2/20 0.43
CDK7 P50613 2/20 0.43
CDK9 P50750 2/20 0.43
CCNT1 O60563 1/20 0.43
CCND1 P24385 1/20 0.43
CCNH P51946 1/20 0.43
CHEK1 O14757 1/20 0.43
NTRK2 Q16620 1/20 0.43
GSK3B P49841 1/20 0.42
SYK P43405 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13898381 0.88 CDK1 (0.67) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL13898557 0.86 CDK1 (0.60) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL3872095 0.85 CDK2 (0.59) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL13897549 0.83 CDK1 (0.70) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL13898570 0.82 CDK2 (0.69) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL13897631 0.80 CDK1 (0.65) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL3870543 0.80 CDK1 (0.65) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL4025895 0.79 CDK1 (0.70) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL4019758 0.79 CDK1 (0.70) CDK1CDK2CCNB1CCNE1CA2
SCHEMBL14498989 0.79 CDK2 (0.64) CDK1CDK2CCNB1CCNE1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 US disclosed
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 US disclosed